2Anderlini P, Rizzo J D, Nugent M L, et al. Peripheral blood stem cell donation: an analysis from the international bone marrow transplant registry (IBMTR) and european group for blood and marrow transplant (EB-MT) databases. Bone Marrow Transplantation, 2001,27: 689-- 692.
3Brasel K, McKenna H J, Charrier K, et al. Flt3 ligand synergizes with granulocyte-macrophage colony-stimulating factor or granulocyte colony-stimulating factor to mobilize hematopoietic progenitor cells into the peripheral blood of mice.Blood,1997,90:3781-3788.
4Anderlini P, Przepiorka D, Korbling M, et al. Blood stem cell procurement: donor safety issues. Bone Marrow Transplantation, 1998, 21(Suppl) :3S35--39.
5Anderlini P, Korbling M. The use of mobilized peripheral blood stem cells from normal donors for allografting. Stem-Cells, 1997, 15: 9--17.
6Anderlini P, Korbling M, Chan K W,et al. Long-term follow-up and safety of normal peripheral blood progenitor cell donors treated with filgrastim: the MD anderson cancer center experience [abstract]. Blood, 2001, 98:183--187.
7Theilgaard M K, Raaschou J K, Andersen H, et al.Single leukapheresis products collected from healthy donors after the administration of granulocyte colony-stimulating factor contain ten-fold higher numbers of longterm reconstituting hematopoietic progenitor cells than conventional bone marrow allografts. Bone-MarrowTransnlant, 1999, 23: 243--249.
8Hoef M V. HLA-identical sibling peripheral blood progenitor cell transplants (PBPCT). Bone Marrow Transplant, 1999. 24: 707--714.
9Ottiger H D. Scheulen B. Beelen D W, et al. Immune reconstitution after allogeneic peripheral blood progenitor cell transplantation [abstract]. Bone marrow transplantation, 1996, 17 (Supp12):135--139.
10Clark L, Clark O, Djulbegovic B, et al. Allogeneic peripheral blood stem cells vs bone marrow transplantation for the therapy of hematological malignancies: a meta-analysis of randomized controlled trials [abstract].Blood, 2001, 98:414--417.
1Jing-Ting Jiang, Chang-Ping Wu, Lu-Jun Chen, Xiao Zheng, Department of Tumor Biological Treatment, Third Affiliated Hospital of Soochow University, Changzhou 213003, Jiangsu Province, China Yi-Bei Zhu, Jing Sun, Xue-Guang Zhang, Key Laboratory of Stem Cell of Jiangsu Province, Institute of Biotechnology, Key Laboratory of Clinical Immunology of Jiangsu Province, Soochow University, Suzhou 215123, Jiangsu Province, China Yue-Ping Shen, Wen-Xiang Wei, Department of Medicine, Soochow University, Suzhou 215123, Jiangsu Province, China Bin-Feng Lu, Department of Immunology, University of Pitts- burgh School of Medicine, Pittsburgh, PA 15261, United States.Increasing the frequency of CIK cells adoptive immunotherapy may decrease risk of death in gastric cancer patients[J].World Journal of Gastroenterology,2010,16(48):6155-6162. 被引量：83
